Instylla Announces the Appointment of Daniel Davis to Board of Directors
BEDFORD, Mass., – Apr 15, 2025 – Instylla, Inc., a privately held clinical-stage company developing solutions for peripheral vascular embolization, has announced the appointment of Daniel Davis to its Board of Directors. Mr. Davis is Chief Strategy Officer at Imperative Care, where he has led growth, development, and strategic initiatives for its stroke and vascular technologies. […]